Director’s Foreword – Cancer Science Institute of Singapore (CSI)
Professor Daniel G. Tenen Director, Cancer Science Institute of Singapore Distinguished Professor in Medicine, National University of Singapore
Welcome to the Cancer Science Institute of Singapore.
We are a dynamic research institute encompassing basic and translational studies devoted to understanding the pathogenesis and treatment of cancer. The Institute is enhanced through the synergistic collaboration between basic scientists and clinician-scientists. Our team of dynamic scientists have established outstanding national and international reputations in their respective fields. Our research teams are committed to conduct ground-breaking research and produce novel developments in their research.
With two strong multidisciplinary programs, the Cancer Stem Cells & Biology Program and the Experimental Therapeutics Program, our research span the spectrum from laboratory based studies in experimental models to targeted therapies in humans, utilizing the expertise from both programs. Capitalizing on these programs, as well as the study and understanding of RNA biology processes under the RNA Biology Centre (RBC), we continue to focus on specific disease areas of relevance to Singapore.
Since its inception in 2008, the Cancer Science Institute of Singapore has achieved multiple awards and honors which our scientists and students have obtained. We have also successfully established and grown the CSI PhD Graduate Program in Cancer Biology, and recently launched our inaugural CSI RNA Biology Scholarship, focusing on RNA biology PhD projects. The impact, breadth and quality of the institute’s research is evident in our list of publications in high-impact scientific journals.
CSI will strive towards our mission of leading and promoting cancer research in Singapore, and continually foster global scientific partnerships, with a vision to be the premier cancer science institute in Asia and a world leader.